Loading clinical trials...
Loading clinical trials...
Phase II Trial of Aerobic Training in Metastatic Breast Cancer
This study is being done to examine the safety and feasibility of a supervised progressive exercise program in women diagnosed with metastatic breast cancer. Previous research among women with metastatic breast cancer has shown that some of the treatments commonly used in this population may have an adverse impact on physical fitness levels leading to feelings of fatigue and poor quality of life. Supervised exercise training has been shown to reduce some of these side-effects in women with early-stage breast cancer receiving common cancer treatments. However, it is not known if supervised exercise training is a safe and feasible intervention in women with metastatic breast cancer. This study is designed to find out if supervised exercise training is safe as the patients undergo treatments for metastatic breast cancer.
Age
21 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Start Date
December 1, 2010
Primary Completion Date
April 4, 2023
Completion Date
April 4, 2023
Last Updated
April 6, 2023
27
ACTUAL participants
Progressive Stretching Group
BEHAVIORAL
Nonlinear Aerobic Training
BEHAVIORAL
Blood draw
OTHER
Cardiopulmonary Exercise Testing (CPET)
OTHER
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Collaborators
NCT06625775
NCT06649331
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions